Financial statements Synektik Pharma
Balance sheet of Synektik Pharma
Company age:
Age:
14 y. 3 m. 22 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of SYNEKTIK PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 38 520 746,46 | 42 228 149,20 | 41 570 196,61 | 38 427 745,77 | 40 386 806,88 |
| A. Fixed assets | 31 019 691,19 | 32 935 422,43 | 31 610 313,73 | 30 845 288,28 | 29 935 572,73 |
| B. Current assets | 7 501 055,27 | 9 292 726,77 | 9 959 882,88 | 7 582 457,49 | 10 451 234,15 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 38 520 746,46 | 42 228 149,20 | 41 570 196,61 | 38 427 745,77 | 40 386 806,88 |
| A. Equity | 16 100 313,92 | 20 672 275,68 | 24 569 315,43 | 26 733 320,94 | 31 138 152,27 |
| B. Liabilities and provisions for liabilities | 22 420 432,54 | 21 555 873,52 | 17 000 881,18 | 11 694 424,83 | 9 248 654,61 |
| I. Long-term liabilities | 12 711 643,38 | 11 094 857,40 | 7 605 542,64 | 4 300 000,00 | 2 700 000,00 |
| II. Short-term liabilities | 8 775 254,23 | 8 222 783,80 | 7 037 010,10 | 5 013 826,49 | 4 123 884,50 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.